Patents by Inventor AstraZeneca, Intellectual Property

AstraZeneca, Intellectual Property has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130158026
    Abstract: The invention concerns chromenone derivatives of Formula I or a pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, R6, R7, R8, n and R9 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.
    Type: Application
    Filed: February 13, 2013
    Publication date: June 20, 2013
    Applicant: AstraZeneca Intellectual Property
    Inventor: AstraZeneca Intellectual Property
  • Publication number: 20130150366
    Abstract: Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use in the treatment of bacterial infections are also described.
    Type: Application
    Filed: February 5, 2013
    Publication date: June 13, 2013
    Applicant: ASTRAZENECA, INTELLECTUAL PROPERTY
    Inventor: AstraZeneca, Intellectual Property